Novavax, Inc.
US ˙ NasdaqGS ˙ US6700024010

SecurityNVAX / Novavax, Inc.
InstitutionStandard Life Aberdeen plc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Standard Life Aberdeen plc closes position in NVAX / Novavax, Inc.

On November 7, 2025 - Standard Life Aberdeen plc filed a 13F-HR form disclosing ownership of 0 shares of Novavax, Inc. (US:NVAX) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on July 24, 2025 disclosing 37,188 shares of Novavax, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-07 2025-09-30 13F NOVAVAX COM NEW 670002401 0 -37,188 -100.00 0 -100.00
2025-07-24 2025-06-30 13F NOVAVAX COM NEW 670002401 37,188 -26,612 -41.71 234 -42.65 0.0004
2025-05-13 2025-03-31 13F NOVAVAX COM NEW 670002401 63,800 0 0.00 409 -20.31 0.0008
2025-01-24 2024-12-31 13F NOVAVAX COM NEW 670002401 63,800 0 0.00 513 -36.40 0.0010
2024-10-25 2024-09-30 13F NOVAVAX COM NEW 670002401 63,800 0 0.00 806 -0.25 0.0015
2024-08-09 2024-06-30 13F NOVAVAX COM NEW 670002401 63,800 0 0.00 808 165.46 0.0015
2024-05-09 2024-03-31 13F NOVAVAX COM NEW 670002401 63,800 0 0.00 305 -0.65 0.0006
2024-01-31 2023-12-31 13F NOVAVAX COM NEW 670002401 63,800 63,800 306 0.0007
2022-08-04 2022-06-30 13F NOVAVAX COM NEW 670002401 0 -7,000 -100.00 0 -100.00
2022-05-04 2022-03-31 13F NOVAVAX COM NEW 670002401 7,000 2,272 48.05 519 -23.22 0.0013
2022-02-10 2021-12-31 13F/A-1 NOVAVAX COM NEW 670002401 4,728 41 0.87 676 -30.45 0.0015
2022-02-08 2021-12-31 13F NOVAVAX COM NEW 670002401 4,728 41 676 0.0005
2021-11-15 2021-09-30 13F NOVAVAX COM NEW 670002401 4,687 2,961 171.55 972 165.57 0.0022
2021-08-10 2021-06-30 13F NOVAVAX COM NEW 670002401 1,726 1,726 366 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.